NIH ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development
01/07/2020
The authors conclude that large, randomized, controlled trials of SARS-CoV-2 are the fastest and most effective path forward for establishing vaccine safety and efficacy.